Disease details

Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03995810 (ClinicalTrials.gov)	June 15, 2019	18/6/2019	Oral Carnosine for Neuromuscular Performance in Multiple Sclerosis	Oral Carnosine for Neuromuscular Performance, Brain Biomarkers of Carnosine Metabolism and Health-related Quality of Life in Multiple Sclerosis	Multiple Sclerosis	Dietary Supplement: Carnosine , capsulle, 2 g/day, 8 weeks	University of Novi Sad, Faculty of Sport and Physical Education	CarnoMed	Completed	18 Years	65 Years	All	3	N/A	Serbia
2	NCT03418376 (ClinicalTrials.gov)	February 1, 2017	9/1/2018	Carnosine Loading and Periodized Training in MS and HC	The Impact of Carnosine Loading and Rehabilitation Therapy on Exercise Capacity in Multiple Sclerosis.	Multiple Sclerosis;Exercise Therapy;Dietary Supplement	Dietary Supplement: Beta-alanine supplementation;Other: Exercise intervention	Hasselt University	NULL	Completed	18 Years	75 Years	All	45	N/A	Belgium